Antinuclear Antibodies in Ankylosing Spondylitis, Psoriatic Arthritis, and Psoriasis.

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/ard.38.6.526
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Real-World Data on Secukinumab Use for Psoriatic Arthritis and Ankylosing Spondylitis

Therapeutic Advances in Musculoskeletal Disease
RheumatologyOrthopedicsSports Medicine
2019English

IMPROVE: Mortality in Psoriasis and Psoriatic Arthritis

British Journal of Dermatology
DermatologyMedicine
2019English

Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis

Journal of managed care & specialty pharmacy
Health PolicyPharmacyPharmaceutical Science
2017English

Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2017English

Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study

Arthritis Care and Research
Rheumatology
2018English

Association Between Use of Disease-Modifying Antirheumatic Drugs and Diabetes in Patients With Ankylosing Spondylitis, Rheumatoid Arthritis, or Psoriasis/Psoriatic Arthritis: A Nationwide, Population-Based Cohort Study of 84,989 Patients

Therapeutics and Clinical Risk Management
2017English

Ixekizumab: Targeting Plaque Psoriasis and Psoriatic Arthritis

Prescriber
Pharmacology
2019English

Which Psoriasis Patients Develop Psoriatic Arthritis?

Psoriasis Forum
2010English

AB0733 Associations of Serum Osteoprotegerin and Il-18 Concentrations With Cardiovascular Risk in Ankylosing Spondylitis and Psoriatic Arthritis Patients

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy